Advanced Pharma

440 papers and 20.0k indexed citations i.

About

In recent decades, authors affiliated with Advanced Pharma have published 440 papers, which have received a total of 20.0k indexed citations. Scholars at this organization have produced 140 papers in Molecular Biology, 46 papers in Cognitive Neuroscience and 39 papers in Epidemiology on the topics of Hearing Loss and Rehabilitation (39 papers), Noise Effects and Management (24 papers) and Hearing, Cochlea, Tinnitus, Genetics (21 papers). Their work is cited by papers focused on Molecular Biology (8.3k citations), Oncology (3.0k citations) and Epidemiology (2.7k citations). Authors at Advanced Pharma collaborate with scholars in United States, Japan and Italy and have published in prestigious journals including Nature, Science and Proceedings of the National Academy of Sciences. Some of Advanced Pharma's most productive authors include Albert P. Li, Céline Gélinas, Eileen White, Eddy Arnold, Cory Abate‐Shen, Leonard C. Edelstein, Cailin Chen, Kalyan Das, Yongjun Fan and Michael M. Shen.

In The Last Decade

Fields of papers published by authors at Advanced Pharma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Advanced Pharma at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Advanced Pharma at the time of their publication.

Countries citing scholars working at Advanced Pharma

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Advanced Pharma. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Advanced Pharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Advanced Pharma more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025